FDA Inspection
Fagron Compounding ServicesFagron Compounding Services – FDA Inspection, Sep 21, 2016
Record Details
This FDA Inspection record concerns Fagron Compounding Services, with an inspection on September 21, 2016, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Fagron Compounding Services
- Inspection Date
- September 21, 2016
- Product Type
- Drugs
View Company Profile
ID · 9bbb41ca-2803-416e-ba42-f3fd62acbebc
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 987526
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
4- 21 CFR 211.28(a)Clothing appropriate for duties performed
- 21 CFR 211.113(b)Procedures for sterile drug products
- 21 CFR 211.165(a)Testing and release for distribution
- 21 CFR 211.192Investigations of discrepancies, failures
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Fagron Compounding Services
4| Date | Classification | Office | Project area |
|---|---|---|---|
| August 8, 2025 | Not classified | Kansas City District Office | Drug Quality Assurance |
| June 28, 2024 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 24, 2022 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 21, 2019 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Fagron Compounding Services
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.